|
Featured News Monthly Roundup - June 2011
June 2011Abuse-resistant Pain Drug Oxecta™ Approved With New AVERSION® Technology Oxycodone pain drug Oxecta™ approved with added benefit to help combat opioid abuse Read more... Read more...
New Drug Approvals
The following drugs have recently been approved by the FDA.
New Indications and Dosage Forms
Drugs that have gained FDA approval for the treatment of additional diseases/conditions or new dosage forms/regimens.
First-Time Generic Approvals
First Time Generics are those drug products that have never been approved before as generic drug products and are new generic products to the marketplace.
Budesonide Capsules 3 mg
Approved: May 16, 2011 - Mylan Pharmaceuticals Inc.
Generic for: Entocort EC
FDA Drug Safety Labeling Changes
This is a summary of the FDA drug labeling changes for May 2011. Click on a drug name to view the changes in more detail.
| Key to Label Sections: |
| BW - Boxed Warning |
C - Contraindications |
| W - Warnings |
P - Precautions |
| AR - Adverse Reactions |
PPI - Patient Package Insert |
| MG - Medication Guide |
PCI - Patient Counseling Information |
| |
Sections Modified |
| Drug Name |
BW |
C |
W |
P |
AR |
PPI |
MG |
PCI |
Imuran (azathioprine) Tablets and Injection |
x |
- |
x |
- |
x |
- |
- |
- |
Biaxin Filmtab (clarithromycin tablets, USP)Biaxin XL Filmtab (clarithromycin extended-release tablets)Biaxin Granules (clarithromycin for oral suspension, USP) |
- |
x |
x |
- |
x |
- |
- |
- |
Afinitor (everolimus) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Aldactazide (spironolactone/hydrochlorothiazide) Tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Avandia (rosiglitazone maleate)Avandamet (rosiglitazone maleate/metformin hydrochloride)Avandaryl (rosiglitazone maleate/glimepiride) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) Tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Genotropin (somatropin [rDNA origin] for Injection |
- |
- |
x |
x |
x |
- |
- |
- |
Humalog (insulin lispro [rDNA origin]) Injection |
- |
- |
x |
x |
- |
- |
- |
- |
Levatol (penbutolol sulfate) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Micardis HCT (telmisartan/hydrochlorothiazide) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Norditropin Cartridges (somatropin [rDNA origin] injection) |
- |
- |
x |
x |
x |
- |
- |
- |
Purinethol (mercaptopurine) Tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Seroquel XR (quetiapine fumarate) Extended-Release |
- |
- |
x |
x |
- |
- |
- |
- |
Seroquel (quetiapine fumarate) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Sutent (sunitinib malate) Capsules |
- |
- |
x |
x |
x |
- |
- |
- |
Teveten HCT (eprosartan mesylate/hydrochlorothiazide) Tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Uniretic (moexipril hydrochloride/hydrochlorothiazide) |
- |
- |
x |
- |
- |
- |
- |
- |
Zegerid (omeprazole/sodium bicarbonate) Capsules and Powder for Oral Suspension |
- |
- |
x |
x |
x |
- |
- |
- |
Ziac (bisoprolol fumarate/hydrochlorothiazide) Tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Azor (amlodipine and olmesartan medoxomil) Tablets |
- |
- |
- |
x |
x |
- |
- |
- |
Capoten (captopril) Tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Exforge (amlodipine/valsartan) Tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Lexiva (fosamprenavir calcium) Tablets and Oral Suspension |
- |
- |
- |
x |
- |
- |
- |
- |
Teveten (eprosartan mesylate) Tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Valturna (aliskiren/valsartan) Tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Benicar (olmesartan medoxomil) Tablets |
- |
- |
- |
- |
x |
- |
- |
- |
Vibramycin (doxycycline monohydrate) Oral Suspension |
- |
- |
- |
- |
x |
- |
- |
- |
Vibra-Tabs (doxycycline hyclate) |
- |
- |
- |
- |
x |
- |
- |
- |
Foradil Aerolizer (formoterol fumarate inhalation powder) |
- |
- |
- |
- |
- |
- |
- |
- |
Note: the drug safety labeling changes listed above may not be a complete list. Please visit the link below for the entire current list and historical archive.
Other Drug News
FDA Panel Rejects Avastin for Breast Cancer
June 29, 2011 The blockbuster cancer drug Avastin got soundly rejected late Wednesday as a treatment for metastatic breast cancer by a United States health advisory panel that found the medication was not effective and causes dangerous side effects.
New Drug Effectively Treats Hepatitis C
June 22, 2011 The recently approved drug Incivek, combined with two standard drugs, is highly effective at treating hepatitis C, a notoriously difficult-to-manage liver disease, two new studies show.
Most U.S. Kids Get Recommended Vaccines: CDC
June 9, 2011 Although nearly all American children get the recommended vaccinations to prevent serious diseases, many parents express concerns about the shots, and a small number refuse to have their kids inoculated, according to the Centers for Disease Control and Prevention.
Melanoma Vaccine Shows Promise in Trial
June 1, 2011 For patients with advanced melanoma, the most dangerous type of skin cancer, a vaccine combined with an immune-boosting drug is showing promise in a large clinical trial. |
|
|
FDA MedWatch Alerts
Tools & Helpful Links
Medical EncyclopediaUse this feature to find information on diseases, symptoms, injuries, medical tests and surgical procedures.
Pill IdentifierThe Pill Identifier enables a search for unidentified pills by imprint code or shape/color.
Drug Interactions CheckerIncreasingly popular as more healthcare professionals and consumers make the effort to seek detailed information on drug-drug and drug-food interactions.
New DrugsAll the latest information on FDA Approvals and recent additions to the database.
News & ArticlesRoundup of recent drug-related news and press releases. also latest news from FDA Medwatch service including timely publication of recalls, withdrawals, warnings, and label/packaging changes.
About This Newsletter
Drugs.com is not affiliated with any pharmaceutical company. We are dedicated to providing consumers and health professionals with objective information about prescription-medication discoveries and side effects.
This information is not intended to be medical advice. You should contact your physician before making any changes to your health care. Drugs.com is not responsible for content provided by third-party web sites.
About Your Subscription
We sent this e-mail to %PERS_EMAIL% at your request.
Your Feedback
We always appreciate feedback so if you wish to give us your comments/ praise/ rebuke please Contact Us.
Thanks so much for your continued support!
The Editorial Team
Drugs.com
|